Mereo BioPharma Group PLC Share Price London S.E.
Equities
GB00BZ4G2K23
Biotechnology & Medical Research
Sales 2024 * | 27.5M 34.81M 2.75B | Sales 2025 * | 12.5M 15.82M 1.25B | Capitalization | 329M 417M 32.94B |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.13M -800M | Net income 2025 * | -28M -35.44M -2.8B | EV / Sales 2024 * | 7.31 x |
Net cash position 2024 * | 128M 163M 12.85B | Net cash position 2025 * | 142M 180M 14.21B | EV / Sales 2025 * | 15 x |
P/E ratio 2024 * |
-314
x | P/E ratio 2025 * |
-63.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.94% |
Managers | Title | Age | Since |
---|---|---|---|
John P. Richard
FOU | Founder | 66 | 28/02/15 |
Founder | 64 | 09/07/15 | |
Charles Sermon
FOU | Founder | 55 | 28/02/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 22/04/19 |
Director/Board Member | - | 09/11/22 | |
Director/Board Member | 59 | 22/04/19 |
1st Jan change | Capi. | |
---|---|---|
+6.77% | 111B | |
+11.05% | 106B | |
-12.87% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-10.18% | 16.81B | |
+38.73% | 12.54B | |
-24.61% | 8.09B |